SCHEMBL4656973

SCHEMBL4656973

O=C(O)CCc1ccc(CCCCCCc2ccccc2)cc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.81
RXFP1 Q9HBX9 1/20 0.81
FFAR1 O14842 9/20 0.80
KEAP1 Q14145 1/20 0.79
HDAC1 Q13547 5/20 0.73
HDAC2 Q92769 2/20 0.73
HDAC3 O15379 1/20 0.73
MAPK1 P28482 1/20 0.73
ADRA1A P35348 1/20 0.73
HDAC4 P56524 1/20 0.73
SLC6A3 Q01959 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
HDAC7 Q8WUI4 1/20 0.73
HDAC10 Q969S8 1/20 0.73
HDAC11 Q96DB2 1/20 0.73
HDAC8 Q9BY41 1/20 0.73
HDAC6 Q9UBN7 1/20 0.73
HDAC9 Q9UKV0 1/20 0.73
HDAC5 Q9UQL6 1/20 0.73
FFAR4 Q5NUL3 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7827706 0.94 MAPT (0.69) MAPTRXFP1FFAR1KEAP1HDAC1
SCHEMBL2553009 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL1008757 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL2554345 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL5955839 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL1008045 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL2555645 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL503837 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
SCHEMBL770290 0.89 MAPT (1.00) MAPTRXFP1KEAP1HDAC1HDAC2
Phenylbutanoic Acid SCHEMBL7431736 0.89 HDAC3 (0.91) MAPTRXFP1FFAR1KEAP1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391199-B1 CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO (JP) 2008-12-10 EP disclosed
US-20070088027-A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient ONO PHARMACEUTICAL CO., LTD. 2007-04-19 US disclosed
US-7179817-B2 Carboxylic acid derivatives and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-20 US disclosed
US-20040224941-A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2004-11-11 US disclosed
EP-1391199-A1 CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2004-02-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088027-A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient EDF1, FFAR1, EDNRA MAPT 1148/4885RXFP1 1357/4885FFAR1 2/4885
US-20040224941-A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient EDF1, FFAR1, VCAM1 MAPT 874/4885RXFP1 1139/4885FFAR1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.